Posts by Steve Rodriguez, PhD
-
Artificial Intelligence Identifies Candidates for Drug Repurposing in Alzheimer's Disease
Drug repurposing in Alzheimer's disease (DRIAD), a machine learning framework developed at Massachusetts General Hospital, screens currently available drugs that might serve as treatments for Alzheimer's disease—and examines unexplored targets for therapy.
Biography
I am an instructor at the MassGeneral Institute for Neurodegenerative Diseases, Department of Neurology, Massachusetts General Hospital. I am also a member of the Laboratory of Systems Pharmacology at Harvard Medical School. I obtained my Ph.D. in Genetics and Development from Cornell University in Ithaca, NY, in the laboratory of David M. Lin.
